![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/vicores-buloxibutid-bet-pays-pulmonary-fibrosis-drug-improves-lung-function-phase-2
https://www.clinicaltrialsarena.com/news/vicore-first-endothelial-dysfunction/
https://www.pharmatimes.com/news/vicore_begins_vital_endothelial_dysfunction_study_1491286
https://www.pharmiweb.com/press-release/2023-05-03/vicore-initiates-clinical-proof-of-concept-study-of-endothelial-dysfunction
https://www.prnewswire.com/news-releases/vicore-announces-first-patient-enrolled-in-companion-a-digital-therapeutic-pivotal-study-for-patients-with-pulmonary-fibrosis-301694342.html
https://news.cision.com/vicore-pharma-holding-ab/r/vicore-announces-new-data-from-the-ipf-air-trial-further-strengthening-the-benefit-risk-profile-of-c,c3661192
https://www.prnewswire.com/news-releases/vicores-digital-therapeutic-for-ipf-patients-shows-nearly-50-anxiety-reduction-in-pilot-study-301642353.html
https://www.prnewswire.com/news-releases/vicore-announces-that-c21-promotes-vascular-function-in-humans-301630636.html
https://www.prnewswire.com/news-releases/vicore-ipf-interim-data-selected-as-an-oral-late-breaker-at-the-ers-congress-301607387.html
https://www.prnewswire.com/news-releases/vicore-announces-first-human-dosed-with-novel-atrag-c106-301569303.html